SLC2A1 and carcinoma: Hirashita et al. evaluated GLUT-1 and FDG-PET/CT using 39 IPMN pancreatic resection specimens, and found that the expression of GLUT-1 was significantly higher in carcinoma than in adenoma, showing that there is a correlation between SUV-max and the expression of GLUT-1 [37].